663 related articles for article (PubMed ID: 21177311)
1. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
[TBL] [Abstract][Full Text] [Related]
2. [Evidence of follicle responsiveness to FSH by antimüllerian hormone in ovulating women].
Scheffer JB; Lozano DM; Frydman R; Bussab A; Taieb J; Fanchin R
Rev Bras Ginecol Obstet; 2009 Mar; 31(3):142-7. PubMed ID: 19547890
[TBL] [Abstract][Full Text] [Related]
3. The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy.
Grynberg M; Pytel S; Peigne M; Sonigo C
Hum Reprod; 2023 Jun; 38(6):1162-1167. PubMed ID: 36961937
[TBL] [Abstract][Full Text] [Related]
4. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome.
Gallot V; Berwanger da Silva AL; Genro V; Grynberg M; Frydman N; Fanchin R
Hum Reprod; 2012 Apr; 27(4):1066-72. PubMed ID: 22279090
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.
Fanchin R; Schonäuer LM; Righini C; Frydman N; Frydman R; Taieb J
Hum Reprod; 2003 Feb; 18(2):328-32. PubMed ID: 12571169
[TBL] [Abstract][Full Text] [Related]
6. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.
Fanchin R; Méndez Lozano DH; Louafi N; Achour-Frydman N; Frydman R; Taieb J
Hum Reprod; 2005 Mar; 20(3):747-51. PubMed ID: 15618255
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
11. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
14. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.
Xu J; Bishop CV; Lawson MS; Park BS; Xu F
Hum Reprod; 2016 Jul; 31(7):1522-30. PubMed ID: 27165618
[TBL] [Abstract][Full Text] [Related]
16. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT).
Genro VK; Matte U; De Conto E; Cunha-Filho JS; Fanchin R
J Assist Reprod Genet; 2012 Jul; 29(7):657-63. PubMed ID: 22527896
[TBL] [Abstract][Full Text] [Related]
17. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.
Dumesic DA; Lesnick TG; Stassart JP; Ball GD; Wong A; Abbott DH
Fertil Steril; 2009 Jul; 92(1):217-21. PubMed ID: 18675414
[TBL] [Abstract][Full Text] [Related]
18. Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status.
Fanchin R; Louafi N; Méndez Lozano DH; Frydman N; Frydman R; Taieb J
Fertil Steril; 2005 Jul; 84(1):167-73. PubMed ID: 16009173
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
20. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimüllerian hormone levels on cycle day 3.
Grynberg M; Genro V; Gallot V; El-Ali A; Frydman R; Fanchin R
Fertil Steril; 2010 Oct; 94(5):1827-31. PubMed ID: 19878941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
